Schwartz R H, Fathman C G, Sachs D H
J Immunol. 1976 Apr;116(4):929-35.
Pools of high titered alloantisera were raised by immunizing (B10.A/SgSn X A/WySn)F1 mice with C57BL/10Sn(B10) spleen cells. This serum (F1 anti-B10), when added to one-way mixed lymphocyte cultures (MLC), inhibited stimulation of B10.A splenic responders by both B10 and B10.D2/nSn irradiated, splenic stimulators. The B10 stimulation was suppressed approximately 85% whereas the mean suppression of B10.D2 stimulation was approximately 60%. In the ofrmer case, the serum contained antibodies reactive with multiple major histocompatibility complex determinants on the stimulator cells. In the latter case, the cytoxic reactivity of the serum was directed principally against an I region-associated determinant Ia.8) shared by B10 and B10.D2 and coded for by a gene(s) in the I-A subregion. The magnitude of the suppression of the response to B10.D2 cells (60%) was similar to the reduction in stimulation observed when the Ia.8 difference was eliminated genetically by using (B10 X B10.A)F1 responder cells against irradiated B10.D2 stimulators. Ihhibition of MLC by this antiserum was a function of reactivity with stimulator and not responder cells. Although some pools of F1 anti-B10 antiserum produced partial inhibition of the responder cell in a B10.D2 vs B10.Ax MLC combination, the results were inconsistent and not correlated with the anti-Ia.8 cytotoxicity titers. In addition, an F1 anti-B10 antiserum pool, which consistently failed to inhibit the responder cell, nevertheless inhibited both irradiated B10.D2 and (B10.A X B10.D2)F1 cells from stimulating B10.A responder cells. However, this same antiserum did not inhibit stimulation of B10.D2 responder cells by the (B10.A X B10.D2)F1 stimulators. Thus, the binding of antibodies to the non-stimulating antigens on the F1 stimulator cell did not interfere with the capacity of the appropriate stimulating antigens to cause stimulation. All of these results are consistent with the hypothesis that Ia allo-antigens are the major stimulating determinants of I region-associated MLC reactions.
通过用C57BL/10Sn(B10)脾细胞免疫(B10.A/SgSn×A/WySn)F1小鼠,制备了高滴度同种异体抗血清库。这种血清(F1抗B10)加入单向混合淋巴细胞培养物(MLC)中时,可抑制经照射的B10和B10.D2/nSn脾细胞刺激B10.A脾反应细胞。对B10刺激的抑制率约为85%,而对B10.D2刺激的平均抑制率约为60%。在前一种情况下,血清中含有与刺激细胞上多个主要组织相容性复合体决定簇反应的抗体。在后一种情况下,血清的细胞毒性反应主要针对B10和B10.D2共有的、由I-A亚区基因编码的I区相关决定簇Ia.8。对B10.D2细胞反应的抑制程度(60%)与使用(B10×B10.A)F1反应细胞对抗经照射的B10.D2刺激细胞时观察到的刺激减少相似。这种抗血清对MLC的抑制作用是与刺激细胞而非反应细胞反应的结果。尽管一些F1抗B10抗血清库在B10.D2对B10.Ax MLC组合中对反应细胞产生了部分抑制,但结果不一致,且与抗Ia.8细胞毒性滴度无关。此外,一个始终未能抑制反应细胞的F1抗B10抗血清库,却能抑制经照射的B10.D2和(B10.A×B10.D2)F1细胞刺激B10.A反应细胞。然而,同一抗血清并不抑制(B10.A×B10.D2)F1刺激细胞对B10.D2反应细胞的刺激。因此,抗体与F1刺激细胞上非刺激抗原的结合并不干扰适当刺激抗原引起刺激的能力。所有这些结果都与Ia同种异体抗原是I区相关MLC反应的主要刺激决定簇这一假设一致。